Guggenheim Initiates Coverage On enGene Holdings with Buy Rating, Announces Price Target of $34
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Manuel Navas initiates coverage on enGene Holdings (NASDAQ:ENGN) with a Buy rating and a price target of $34.
April 15, 2024 | 11:46 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim initiated coverage on enGene Holdings with a Buy rating and set a price target of $34.
The initiation of coverage by Guggenheim with a Buy rating and a significant price target suggests a strong positive outlook for enGene Holdings. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100